CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural...

Genomics Market is anticipated to reach US$ 49,996.15 Mn by 2027

Genomics Market is anticipated to...

Bionano Genomics Symposium to feature OGM Presentations and Live Panel Discussion

Bionano Genomics Symposium to feature...

What is the Importance of Gene Editing in Farming?

What is the Importance of Gene...

Autolomous and Vineti to Establish a Fully Integrated End-To-End CGT Delivery Pathway Together

Autolomous and Vineti to Establish a...

Genome Editing: What Makes CRISPR-Cas9 a Preferred Choice?

Genome Editing: What Makes...

4 Diseases That Could Be Cured Using CRISPR Technology

4 Diseases That Could Be Cured Using...

Genome Editing Market: Development, Prospective and Regional Vision

Genome Editing Market: Development,...

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural...

Genomics Market is anticipated to reach US$ 49,996.15 Mn by 2027

Genomics Market is anticipated to...

Bionano Genomics Symposium to feature OGM Presentations and Live Panel Discussion

Bionano Genomics Symposium to feature...

What is the Importance of Gene Editing in Farming?

What is the Importance of Gene...

Autolomous and Vineti to Establish a Fully Integrated End-To-End CGT Delivery Pathway Together

Autolomous and Vineti to Establish a...

Genome Editing: What Makes CRISPR-Cas9 a Preferred Choice?

Genome Editing: What Makes...

4 Diseases That Could Be Cured Using CRISPR Technology

4 Diseases That Could Be Cured Using...

Genome Editing Market: Development, Prospective and Regional Vision

Genome Editing Market: Development,...

Retrons: Progressing From Enigma to Engineering Tool

Life Sciences Review | Thursday, October 21, 2021
Tweet

Retrons are attractive because their sequences may be used as barcodes to identify which individuals in a pool of bacteria have received each retron sequence, allowing for much faster-pooled screening of precisely generated mutant strains.


FREMONT CA: Researchers have created a new gene-editing tool named Retron Library Recombineering (RLR) that can produce up to millions of mutations concurrently and 'barcodes' mutant bacterial cells to screen the whole pool at once. It can be employed in situations when CRISPR is toxic or impossible to use, and it improves editing rates.


Retrons are single-stranded DNA fragments produced by reverse transcription of bacterial DNA segments (ssDNA). Retrons have been known for decades, but the role of the ssDNA they make has baffled scientists since the 1980s, when a team eventually discovered out that retron ssDNA discovers whether a virus has infected the cell, developing part of the bacterial immune system.


Retrons were often thought to be little more than a curious bacterial oddity, but in recent years, researchers have been more interested in them because, like CRISPR, they could be utilized for precise and flexible gene editing in yeast, bacteria, and even human cells.


The integration of ssDNA with the desired mutation into an organism's DNA is needed for recombination-based gene editing approaches, which can be accomplished in one of two ways.Double-stranded DNA can be physically cut (for instance, with CRISPR-Cas9) to cause the cell to combine the mutant sequence into its genome during the repair process,


or the mutant DNA strand and a Single-Stranded Annealing Protein (SSAP) can be imported into a replicating cell so that the SSAP combines the mutant strand into the daughter cells' DNA.


Retrons are also attractive because their sequences may be used as barcodes to identify which individuals in a pool of bacteria have received each retron sequence, allowing for much faster-pooled screening of precisely generated mutant strains. To determine if retrons might be used to accomplish successful recombineering, one researcher and his colleagues first constructed circular plasmids of bacterial DNA containing antibiotic resistance genes within retron sequences, as well as an SSAP gene to allow retron sequence integration into the bacterial genome. After 20 generations of cell replication, they put these retron plasmids into E. coli bacteria to check if the genes were successfully incorporated into their genomes. Initially, the required mutation was found in less than 0.1 percent of E. coli carrying the retron recombineering system.


The team made many genetic changes to the bacteria to boost its initial performance. They first turned off the cells' normal mismatch repair mechanism, which corrects DNA replication errors and may have been "fixing" the intended mutations before they could be transmitted down to the next generation. They also turned off two bacterial genes that code for exonucleases, which are enzymes that break down free-floating ssDNA. The proportion of bacteria that integrated the retron sequence expanded rapidly as a result of these alterations, reaching more than 90 percent of the population.


Weekly Brief

loading
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/retrons-progressing-from-enigma-to-engineering-tool-nwid-595.html